Background: In Gram-negative bacteria, the outer-membrane represents an additional barrier for antibiotics to permeate inside pathogens. Our inability to come up with novel effective antibiotics mostly relies upon insufficient understanding of the molecular basis behind outer-membrane penetration. Results: Polar antibiotics can permeate through water-filled porins, such as OmpF and OmpC from Escherichia coli. Through molecular modeling, permeation of imipenem and meropenem was found to be strongly dependent upon capability of drugs to properly align their electric dipole to the internal electric field in the restricted region of the pore. Electrostatics differences between OmpF and OmpC, and modifications along a series of OmpC mutants from E. coli-resistant clinical strains identify a 'preorientation' region, which dramatically affects antibiotic pathway. Conclusion: A novel perspective is presented, suggesting new molecular properties to be included in drug design.
Exploiting the porin pathway for polar compound delivery into Gram-negative bacteria
SCORCIAPINO, MARIANO ANDREA;D'AGOSTINO, TOMMASO;ACOSTA GUTIERREZ, SILVIA;MALLOCI, GIULIANO;BODRENKO, IGOR;CECCARELLI, MATTEO
2016-01-01
Abstract
Background: In Gram-negative bacteria, the outer-membrane represents an additional barrier for antibiotics to permeate inside pathogens. Our inability to come up with novel effective antibiotics mostly relies upon insufficient understanding of the molecular basis behind outer-membrane penetration. Results: Polar antibiotics can permeate through water-filled porins, such as OmpF and OmpC from Escherichia coli. Through molecular modeling, permeation of imipenem and meropenem was found to be strongly dependent upon capability of drugs to properly align their electric dipole to the internal electric field in the restricted region of the pore. Electrostatics differences between OmpF and OmpC, and modifications along a series of OmpC mutants from E. coli-resistant clinical strains identify a 'preorientation' region, which dramatically affects antibiotic pathway. Conclusion: A novel perspective is presented, suggesting new molecular properties to be included in drug design.File | Dimensione | Formato | |
---|---|---|---|
Future Med Chem 2016 Scorciapino.pdf
Solo gestori archivio
Tipologia:
versione editoriale (VoR)
Dimensione
3.44 MB
Formato
Adobe PDF
|
3.44 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.